In recent years, pharma companies have confronted many challenges when recruiting participants in clinical trials. Restricted candidate pools and time-consuming selection processes often hinder efficiency, causing delays that trickle down to trial execution and completion. As the number of national and international clinical trials rises, the availability of high-quality medical expertise has become even harder to locate and develop.
Despite broad recruiting experience, contract research organizations (CROs) and specialized consulting companies used to identify candidates struggle to reach targeted recruitment goals. Delays can be caused by leadership indecision, restrictive selection requirements, and other regulatory barriers. Delays in properly identifying, vetting, and engaging patients, principal investigators (PIs), and medical doctors (MDs) through these methods can extend trial timelines up to several months, impacting pharmaceutical companies’ ability to reach communities with critical new treatments.
Modernizing the Recruitment Process: Innovative Ways to Engage PIs and MDs
Pharmaceutical companies must develop a recruitment process that spans across broad networks of patients, doctors, and principal investigators to find the right fit for future trials. Several innovative recruitment methods can be used to expedite identifying and engaging qualified PIs and MDs:
Leveraging Digital Networks
Expanded use of social media offers a dynamic range of potential participants. From a PI and MD perspective, harnessing the broad scope of these online networks offers pharma companies and their sponsors the opportunity to reach a much wider audience, resulting in greater access to qualified professionals with increased ease and speed.
Involving Patients & Advocacy Groups
Patient advocacy groups often facilitate recruitment by raising awareness within their communities and providing a deeper understanding of patient needs. Pharma companies can leverage these learnings and insights to enhance their trial’s design and accelerate enrollment.
Exploring Technology Advancements
New technologies are revolutionizing the future of clinical trial development and management. The ability to facilitate remote MD-patient interactions through digital health is redefining the boundaries of clinical research. Digital health and Diversified Clinical Trials (DCT) are poised to become the new normal for clinical trial involvement, saving time and creating opportunities for innovation within the trial execution process.
Collaborating with Professional Networks
Collaboration with professional medical associations and medical societies facilitates local access to targeted medical populations for recruitment. These partnerships can help overcome geographical barriers when recruiting a diverse group of medical experts. Established networks can provide a pool of experts who have already indicated interest in clinical trial participation.
Targeting Experts: Outreach & Incentives
The perception that clinical trials take time away from their own practices and patient care often prevents MDs from participating. However, a focused and targeted recruitment strategy tailored to the motivations of potential PIs and MDs can help pharma companies go beyond these barriers, leading to faster recruitment and engagement. Offering incentives from research grants to advanced educational opportunities can also play a pivotal role in attracting and motivating medical experts to participate and actively collaborate throughout the trial.
Creating a Data-Driven Approach
Data analytics and predictive modeling capabilities provide new ways to identify and recruit PIs and MDs who show a high likelihood of interest in joining clinical trials. By analyzing historical trial data, publication records, and overall clinical expertise, predictive models can pinpoint top candidates with greater efficiency. Through these models, pharma organizations can make valuable adjustments to the model based on investigator input and ongoing clinical trial results.
Regardless of the specific changes implemented, the goal is the same: Create new pathways for efficiency and effectiveness that lead to transformation.
At the heart of any successful project—or clinical trial—are the people who make them possible. A recruiting strategy that creatively engages patients, PIs, and MDs, and thoughtfully addresses their needs will improve key facets of the clinical trial experience and the quality of its results.
Transforming your clinical trial recruiting process may include leveraging new incentive frameworks, community-building efforts, or innovative approaches that make use of digital health and predictive analytics capabilities. Regardless of the specific changes implemented, the goal is the same: Create new pathways for efficiency and effectiveness that lead to transformation. These integrated strategies will not only accelerate trial initiation but amplify patient engagement and diversity, advancing medical research and patient care on a global scale.
As medical research progresses, the commitment to ongoing improvement can reshape the clinical trial landscape for the better. With these strategies in place, opportunities for streamlining trial management and expediting the journey from scientific discovery to patient care are within reach.
RELATED INDUSTRIES
RELATED SOLUTIONS
